Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of kinase inhibitors. Its structure supports modification for targeted drug design, especially in oncology and inflammation-related therapies. The bromo functional group allows for cross-coupling reactions, enabling the introduction of various substituents to optimize potency and selectivity. Also employed in the preparation of indazole-based small molecules for use in biochemical assays and receptor binding studies.